| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 08/24/2011 | EP2358392A1 Antibody formulation |
| 08/24/2011 | EP2358390A1 Cd37 immunotherapeutic combination therapies and uses thereof |
| 08/24/2011 | EP2358389A1 Vaccines, which combine the antigen and toll-like receptors |
| 08/24/2011 | EP2121920B1 Method for cloning cognate antibodies |
| 08/24/2011 | EP1856155B1 Monoclonal antibodies and immunodetection assay specific for the chemotactic epitope of the urokinase-type plasminogen activator receptor |
| 08/24/2011 | EP1838733B1 Antibodies directed to angiopoietin-2 and uses thereof |
| 08/24/2011 | EP1745072B1 Method for producing soluble mhc proteins |
| 08/24/2011 | EP1644035B1 Ultrafiltration and ultracentrifugation for preparing outer membrane vesicles |
| 08/24/2011 | EP1636594B1 Method and means for the determination of defined states or modifications in the mucus of the uterus or in the epithelium of other organs |
| 08/24/2011 | EP1546415B1 Anti-tsg101 antibodies and their uses for treatment of viral infections |
| 08/24/2011 | EP1536006B1 Cancer antigens and utilization thereof |
| 08/24/2011 | EP1499729B1 Derivatives of the nf-kappab inducing enzyme, their preparation and use |
| 08/24/2011 | EP1025121B1 Peptides capable of inhibiting the interaction between presenilins and the beta-amyloid peptide or its precursor |
| 08/24/2011 | EP0981618B2 Anti-apo-2 antibody |
| 08/24/2011 | EP0754059B2 Methods and compositions useful for inhibition of angiogenesis |
| 08/24/2011 | CN1954074B Process for producing polypeptides |
| 08/24/2011 | CN1920013B Nevoid basal cell carcinoma syndrome pathogenic gene and encoding protein thereof |
| 08/24/2011 | CN102164965A Biological products |
| 08/24/2011 | CN102164964A Novel antibodies recognizing native annexin A3 |
| 08/24/2011 | CN102164963A Monoclonal antibodies for treatment of cancer |
| 08/24/2011 | CN102164962A Anti-GD2 antibodies and methods and uses related thereto |
| 08/24/2011 | CN102164961A Cross-species-specific PSCAxCD3, CD19xCD3, C-NETxCD3, endosialinxCD3, EpCAMxCD3, IGF-1RxCD3 or FAOalpha xCD3 bispecific single chain antibody |
| 08/24/2011 | CN102164960A Bispecific anti-EGFR/anti-IGF-1R antibodies |
| 08/24/2011 | CN102164959A Antibodies against human IL 17 and uses thereof |
| 08/24/2011 | CN102164958A Humanization of rabbit antibodies using a universal antibody framework |
| 08/24/2011 | CN102164957A Methods and compositions for discovery of target-specific antibodies using antibody repertoire array (ARA) |
| 08/24/2011 | CN102164956A Novel antibodies against cancer target block tumor growth, angiogenesis and metastasis |
| 08/24/2011 | CN102161983A Hybridoma cell line secreting I-IV-type dengue virus NS1 monoclonal antibodies and test kit thereof |
| 08/24/2011 | CN102161982A Monoclonal antibodies (McAb) against human CXCR3 molecules and application thereof |
| 08/24/2011 | CN102161703A Method for preparing monoclonal antibody resisting human neuropilin-1 |
| 08/24/2011 | CN101550191B Malignant melanoma T cell nano antibody, coding sequence and application thereof |
| 08/24/2011 | CN101550186B Sheep recombination prion protein and monoclonal antibody thereof and application |
| 08/24/2011 | CN101111521B Humanized antibody specific for tumor necrosis factor-alpha |
| 08/24/2011 | CN101100663B Preparing method for recombinant human anti-rabies monoclonal antibodies |
| 08/24/2011 | CN101098892B Antibodies against IL-13 receptor alpha 1 and uses thereof |
| 08/23/2011 | US8003776 Mycobacterial antigens expressed during latency |
| 08/23/2011 | US8003774 Immunoglobulin variat for use in diagnosis, prevention and treatment of infection, nervous system, skin, inflammatory and cell proliferative diseases |
| 08/23/2011 | US8003767 Sulfonated [8,9]benzophenoxazine dyes and the use of their labelled conjugates |
| 08/23/2011 | US8003766 Monoclonal antibody specific to ochratoxin A |
| 08/23/2011 | US8003765 Lipocalin-type prostaglandin D2 synthase specific monoclonal antibody for use in diagnosis of nervous system trauma and dysfunction |
| 08/23/2011 | US8003764 Folliculin-specific antibodies and methods of detection |
| 08/23/2011 | US8003763 for in vitro diagnostics/antitumor agents; gene overexpression of cell surface proteins; bind Cripto and block the interaction between Cripto and activin-like kinase (ALK) 4 |
| 08/23/2011 | US8003762 Monoclonal antibody to CD166 and method for production thereof |
| 08/23/2011 | US8003761 Cancerous disease modifying antibodies |
| 08/23/2011 | US8003758 BPC-1: a secreted brain-specific protein expressed and secreted by prostate and bladder cancer cells |
| 08/23/2011 | US8003753 Fret protease assays for clostridial toxins |
| 08/23/2011 | US8003613 Methods and compositions for inducing apoptosis |
| 08/23/2011 | US8003595 Amino acid sequences facilitating penetration of a substance of interest into cells and/or cell nuclei |
| 08/23/2011 | US8003386 Tumor necrosis factor receptors 6α and 6β |
| 08/23/2011 | US8003383 Vector for efficient selection and/or maturation of an antibody and uses thereof |
| 08/23/2011 | US8003347 Nucleic acids encoding ChemerinR ligands |
| 08/23/2011 | US8003338 Diagnostic method for diseases by screening for hepcidin in human or animal tissues, blood or body fluids and therapeutic uses therefor |
| 08/23/2011 | US8003336 Method of screening endothelial cells for angiogenic capability |
| 08/23/2011 | US8003107 Antibodies to Lawsonia intracellularis |
| 08/23/2011 | US8003104 Method for treating inflammation |
| 08/23/2011 | US8003103 High affinity human antibodies to human IL-18 receptor |
| 08/23/2011 | US8003102 Anti-CXCR4 antibodies |
| 08/23/2011 | US8003101 Inflammatory mediator antagonists |
| 08/23/2011 | US8003100 Antibodies that bind to 238P1B2 |
| 08/23/2011 | US8003075 Diagnostic assay for human matrix GLA-protein and its use as a biomarker |
| 08/23/2011 | CA2574929C Bone morphogenetic protein (bmp)-17 and bmp-18 and compositions |
| 08/23/2011 | CA2428278C Virulence of streptococci |
| 08/23/2011 | CA2342397C Genes from a gene cluster |
| 08/23/2011 | CA2296807C Erbb4 receptor-specific neuregulin related ligands and uses therefor |
| 08/23/2011 | CA2270176C Methylated, smd homologous peptides, reactive with the antibodies from sera of living beings affected with systemic lupus erythematosus |
| 08/23/2011 | CA2203888C Al-1 neurotrophic factor, a ligand for an eph-related tyrosine kinase receptor |
| 08/23/2011 | CA1341620C Envelope antigens of hiv-1 |
| 08/18/2011 | WO2011100538A1 Therapeutic methods using an ti-cd200 antibodies |
| 08/18/2011 | WO2011100493A1 Preparation and/or purification of oligonucleotide conjugates |
| 08/18/2011 | WO2011100477A2 Antibodies and processes for preparing the same |
| 08/18/2011 | WO2011099684A1 Single domain antibody against muc1 |
| 08/18/2011 | WO2011099566A1 Antibody against mucin 1 (muc1) protein and use of same |
| 08/18/2011 | WO2011099524A1 Radioactive metal-labeled anti-cadherin antibody |
| 08/18/2011 | WO2011098526A1 Single unit antibody purification |
| 08/18/2011 | WO2011098520A1 Agonist dr5 binding polypeptides |
| 08/18/2011 | WO2011098518A2 Delivery of immunoglobulin variable domains and constructs thereof |
| 08/18/2011 | WO2011098424A2 Treatment of a metabolic disorder |
| 08/18/2011 | WO2011097733A1 Free hexasaccharide isolated from several campylobacter species |
| 08/18/2011 | WO2011079257A3 Human antibodies to human angiopoietin-like protein 4 |
| 08/18/2011 | WO2011069795A4 Neutralizing prolactin receptor antibodies and their therapeutic use |
| 08/18/2011 | WO2011050027A3 Surface-assisted hemagglutination and hemagglutination inhibition assays |
| 08/18/2011 | WO2011049956A3 Toxicity-associated genes, genetic variants, and use thereof |
| 08/18/2011 | WO2011038302A3 Insulin receptor binding antibodies |
| 08/18/2011 | WO2011029008A3 Synbodies to akt1 |
| 08/18/2011 | WO2011028963A3 Immunogenic hiv composition |
| 08/18/2011 | WO2011019932A3 Compositions and methods for the therapy and diagnosis of influenza |
| 08/18/2011 | WO2011000962A9 Hiv related peptides combination or fusion for use in hiv vaccine composition or as diagnostic means |
| 08/18/2011 | WO2010142952A3 Antibodies |
| 08/18/2011 | WO2009109635A9 Novel antigen binding dimer-complexes, methods of making and uses thereof |
| 08/18/2011 | US20110202281 Adaptive biochemical signatures |
| 08/18/2011 | US20110202000 Anti-amyloid beta antibodies conjugated to sialic acid-containing molecules |
| 08/18/2011 | US20110201986 Method for enhancing immune responses in mammals |
| 08/18/2011 | US20110201947 Oxidized paraoxonase 1 and paraoxonase 1/hdl particle number ratio as risk markers for cardiovascular disease |
| 08/18/2011 | US20110201790 Hybridoma producing antibodies to lawsonia intracellularis |
| 08/18/2011 | US20110201789 Antibodies to lawsonia intracellularis |
| 08/18/2011 | US20110201788 Hybridoma producing antibodies to lawsonia intracellularis |
| 08/18/2011 | US20110201787 Hybridoma producing antibodies to lawsonia intracellularis |
| 08/18/2011 | US20110201786 Hybridoma producing antibodies to lawsonia intracellularis |
| 08/18/2011 | US20110201785 Method for optimizing proteins having the folding pattern of immunoglobulin |
| 08/18/2011 | US20110201670 Oligoribonucleotides and methods of use thereof for treatment of fibrotic conditions and other diseases |